Xcel品牌 XELB 深 滬
等待開盤 01-03 09:30:00 美东时间
1.10
+0.020
+1.85%
華盛通- 最 高1.13
- 今 開1.11
- 成交量 1.25万股
- 最 低 1.06
- 昨 收 1.08
- 總市值 528.75万
- 52周最高 5.489
- 市盈率 靜 --
- 換手率 0.26%
- 52周最低 0.7362
- 委 比 51.22%
- 總股本 480.68万
- 歷史最高 200.00
- 量 比 0.25
- 振 幅 6.48%
- 歷史最低 1.06
- 每 手 1
- 風險率 1.09%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多12 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session
Gainers Autozi Internet Tech (NASDAQ:AZI) shares rose 81.6% to $4.54 during Mo...
2025-12-22 20:05
Xcel Brands Announces $2.05M PIPE Financing With ~1.67M Shares And Common Stock Purchase Warrants To Purchase Up To 835,023 Shares Of Common Stock At A Purchase Price Of $1.2275 Per Share And One-Half Common Stock Purchase Warrant
Xcel Brands, Inc. (NASDAQ:XELB) ("Xcel" or the "Company"), announces today that it has entered into a securities purchase agreement for a private investment in public equity ("PIPE") financing that is expected to result
2025-12-18 04:54
Shares of retail companies are trading higher amid overall market strength after the Fed cut rates by 25 basis points.
Shares of retail companies are trading higher amid overall market strength afte...
2025-12-11 04:32
Earnings Scheduled For November 19, 2025
Companies Reporting Before The Bell • Lowe's Companies (NYSE:LOW) is expected t...
2025-11-19 19:11
A Look at Xcel Brands's Upcoming Earnings Report
Xcel Brands (NASDAQ:XELB) will release its quarterly earnings report on Wednesd...
2025-11-19 00:02
XCel Brands Updates Loan and Security Agreement
XCel Brands ( ($XELB) ) has provided an update. On October 7, 2025, Xcel Brands...
2025-10-11 05:02
11 Consumer Discretionary Stocks Moving In Friday's Intraday Session
Gainers Epsium Enterprise (NASDAQ:EPSM) shares increased by 63.7% to $24.69 du...
2025-10-04 01:06
XCel Brands Stock Soars 66% After-Hours: What's Driving the Surge?
XCel Brands' stock surged 66% after-hours after revealing a settlement and equity transfer agreement with the SEC.
2025-10-03 14:15
美股大行评级 | 升至450美元，瑞穗上调特斯拉目标价；富国银行上调CoreWeave至"超配"，目标价升至170美元
今日重点评级关注：Guggenheim：维持MBX Biosciences"买入"评级，目标价从44美元升至84美元；Oppenheimer：维持MBX Biosciences"跑赢大市"评级，目标价从38美元升至80美元
2025-09-24 10:23
